Taking informed consent and withdrawal

Slides:



Advertisements
Similar presentations
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Informed Consent.
Advertisements

CLRN RESEARCH MIDWIFE PERSPECTIVE By Nicky Grace RM, MA.
Informed consent in research ethics
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
A COPY OF THIS CONSENT FORM HAS BEEN OFFERED TO THE PATIENT
Research and Development Department A Quick Guide to Using EDGE v2 for Researchers Version 1.2 – 23 February
Good Clinical Research Practice Guidelines For Informed Consent Presented by Catherine May Acting Research Practice Development Officer The Office of Research.
The Consent Process: It’s More Than Just a Form A “10 Minute Training” Brought to you by Cyndi Long, MS, RD, CCRC CU Sports Medicine.
Information for Decision Makers Acknowledgement: Adapted from Liverpool CCG, with kind permission.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005.
Developing information for participants in your research - Writing your participant information This presentation will help you to create the first draft.
Baltic Dental Meeting Palanga Dana Romane The Patient in the Centre – Patient’s Involvement in the Treatment Process, Full Awareness and.
British Association of Dermatologists’ Biologics Intervention Register Approval Process July 2007.
Template for study specific training for Intrapartum Research Studies [ Please see guide before using this]
Negotiating access, ethics and the problems of ‘inside’ research.
Paula Peyrani, MD Division of Infectious Diseases University of Louisville The Informed Consent Process.
Mental Capacity Act Practitioners Forum Writing an Advanced Directive.
Module 3: Informed Consent. This training session contains information regarding: Documenting consent Documenting consent Conducting informed consent.
Professor Kristy K. Taylor.  Job Functions:  Roles and qualities of an Office Manager  Motivate and Mentoring Team Members  Certification  The Office.
Personal Health Budgets Evaluation Recruitment Process.
Mette Krag, MD, coordinating investigator
SIFT A multi-centre randomised controlled trial of two speeds of daily increment of milk feeding in very preterm or very low birth weight infants Eligibility.
Wilmington Medical Associates Patient’s Rights & Responsibilities You Have the Right to: Considerate and Respectful Care We respect your right to: expect.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
Applying for ethical approval
Søren Marker Jensen, MD, coordinating investigator
Evaluation.
Prescribing, preparation and administration of the IMP including maintaining blinding V6.0 17/01/17.
Safety Reporting V6.0 17/01/17.
SAFEGUARDING – MENTAL CAPAPCITY ACT.
Randomisation Process
MAINTAINING THE INVESTIGATOR’S SITE FILE
Enrolling in Clinical Trials
The early use of Antibiotics in at Risk CHildren with InfluEnza
HOW TO CONSENT A PATIENT?
Good Clinical Practice (GCP) requirements for ANODE
Incident Management: Recording New Incidents User Guide
Patient Medical Records
Bozeman Health Clinical Research
Consent, throughout the Early Help Journey
Establish a Pre-consultation Process
Interview Study Patient Information Leaflet
Information Pathway and Eligibility Criteria
HOW TO CONSENT A PATIENT?
How we use Your Health Records
Consent Training Module
CONDUCTING THE TRIAL AT
Elements of a Successful Informed Consent
Participant Retention
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Obtaining Informed Consent
Academy Medical Centre
Consent, throughout the Early Help Journey
TRTO (Translational Research Trials Office)
Documentation.
COMMUNITY PHARMACY WORKBOOK 2019 PUBLIC HEALTH DORSET
Recruitment Process.
Understanding the Process of Documenting Informed Consent
Documentation.
Informed Consent Before taking part in this study it is important that you understand: This study aims to evaluate the benefits of lessons on sexually.
Protocol Approval Criteria
RESEARCH METHODS Lecture 14
Documentation.
Presentation transcript:

Taking informed consent and withdrawal V6.0 17/01/17

Who should take consent for the ANODE trial? Any health care professional (site specific) who: Has a good knowledge of the ANODE trial and its aims Has been trained by the ANODE Local Research Midwives (LRMs) on the study, randomisation process, drug administration and taking of consent Has full GCP training Has signed the Delegation Log- and has been signed off by the PI prior to carrying out any ANODE related tasks V6.0 17/01/17

What is informed consent? Giving informed consent is the process by which an individual voluntarily confirms their willingness to participate/allow their inclusion in something that is asked of them It should only be obtained if the individual has been informed of the benefits and risks of taking part in any study or procedure that they consent to V6.0 17/01/17

Taking informed consent Important notes when asking for consent Use language that is easy to understand and free from jargon Use open and approachable body language Actively listen to any concerns she may have Answer all questions asked The woman should understand that by not giving consent it will not affect the standard of care that she receives V6.0 17/01/17

Taking informed consent Because of the difficult timing of taking consent to the trial there are two ways that women may be consented: Where there is no time constraint (e.g. in cases of OVD for delayed second stage), the healthcare professional will discuss the trial with the woman and provide her with the Participant Information Leaflet ‘A’. If she is happy to join the trial informed written consent will be obtained using the Written Consent Form V6.0 17/01/17

Taking informed consent Where there is a time or other constraint (e.g. cases of OVD for suspected fetal compromise or delivery already taken place), women will be approached to give verbal consent recorded on the Verbal Consent Form It is important to also capture emergency cases as they are likely to have received a lower standard of asepsis Please note there is an ANODE Verbal Consent Crib Sheet available to assist with obtaining Verbal Consent V6.0 17/01/17

Verbal Consent Women who provide Verbal Consent must be approached prior to discharge to provide full Written Consent for the inclusion of their data in the trial and participation in the planned follow-up as soon as is possible and prior to discharge Please present the with Participant Information Leaflet ‘B’ prior to obtaining written consent This post verbal written consent should be recorded on the lower section of the Verbal Consent form V6.0 17/01/17

3 point checklist for taking verbal consent 1 Have you explained and has the woman understood the aim of the ANODE trial and what it will involve? 2 Have you explained the possible risks and benefits of the trial and that she is free to withdraw at any time without it affecting her care? 3 Have you explained that she will be required to complete written consent? V6.0 17/01/17

Verbal consent forms Ensure that the study number is entered on the consent form once a woman has been randomised Ensure that the clinician taking verbal consent prints, signs, times and dates the Verbal Consent Form (this must be witnessed) Ensure that the witness prints, signs and dates the Verbal Consent Form (the witness should be a non-clinical person if possible for e.g. birth partner but can be another health professional if no alternative is available) – dates should not be pre-populated PLEASE NOTE: Written consent MUST be sought and recorded on the lower part of the Verbal Consent Form prior to discharge (ideally prior to leaving theatres or delivery suite!) V6.0 17/01/17

6 point checklist for taking written consent 1 Have you given the woman an opportunity to read the Participant Information Leaflet? 2 Have you explained and has the woman understood the aim of the ANODE Trial and what it will involve? 3 Have you explained what a randomised controlled trial is? V6.0 17/01/17

6 point checklist for taking written consent 4 Have you explained the possible risks, possible side effects and benefits of the Trial? 5 Have you explained that the woman is free to withdraw at any time without having to give a reason and without her medical care being affected? 6 Have you explained the purpose of the 6 week follow-up phone call and questionnaire and answered all of her questions? V6.0 17/01/17

Written Consent forms Ensure that the study number is entered onto the consent form following randomisation Ensure all 8 statements are initialed not ticked by the woman The woman and the person taking consent should print, sign and date the form – dates should not be pre-populated for the woman (These points also apply for the written consent section of the Verbal Consent Form) V6.0 17/01/17

What to do if a woman withdraws from the trial? The woman has the right to withdraw from the trial follow-up at any time. Women DO NOT need to give a reason for withdrawing though it may be helpful to discuss the decision with them but this should only be done if they are willing to talk about their decision. It is important that you clarify with the woman and record on the form whether they would agree to retention and use of the data already collected and for data collection to continue. Unless we obtain consent to continue to use data at withdrawal, they will be excluded from future analysis. Depending on the wishes of the woman further data collection and form completion may be required. V6.0 17/01/17

What to do if a woman withdraws from the trial? After consulting the woman complete Form 7: Withdrawal recording their wishes regarding the withdrawal. Please make two photocopies of the completed Form 7 and file one in the woman’s clinical notes and the other 2 copies in the ANODE tray. V6.0 17/01/17